Top Journalists
>
Bret Jensen

Bret Jensen

Contributor, The Biotech Forum at Seeking Alpha

Contact this person
Email address
b*****@*******.comGet email address
Influence score
66
Location
United States
Languages
  • English
Covering topics
  • Biotechnology
  • Health & Medicine

View more media outlets and journalists by signing up to AI PR

View latest data and reach out all from one place
Sign up to AI PR Toolkit

Recent Articles

seekingalpha.com

Medline Inc.: Beware The Private Equity Overhang (NASDAQ:MDLN)

Medline Inc. faces pressure from private equity overhang and a recent downward revision in FY26 adj. EBITDA guidance. I rate the MDLN stock a hold. Read my full analysis.
seekingalpha.com

The Debt Markets Are Starting To Cry Uncle

Surging interest rates and tighter credit markets threaten US stocks, real estate, and debt dynamics. Click for an updated market outlook.
seekingalpha.com

The Real Estate Markets Are Officially Cooked

US housing and commercial real estate are under stress as sales slump, rates stay high, and office delinquencies rise. Read what investors need to know.
seekingalpha.com

The Option Play Of The Week (NASDAQ:OMER)

Shares of complement system biotech Omeros Corporation (OMER) have rallied 406% in the past 11 months, triggered by an out-licensing deal with Novo Nordisk...
seekingalpha.com

A Big Chunk Of 2026's Earnings Growth Is Increasingly Illusionary (...

S&P 500 earnings are concentrated in tech/energy, driven by AI and oil spikes, but cash flow weakens. Click for an updated market outlook.
seekingalpha.com

Welcome To The Hotel California: Private Credit's Woes Mount

Private credit markets continue to deteriorate with default rates rising. Click to read what investors should know about this challenging situation.
seekingalpha.com

Portfolio Change Alert: Adding UroGen Pharma To Model Portfolio (NA...

We are adding a new name to our model portfolio.  This change will be effective upon market close today.  These shares can be accumulated either by...
seekingalpha.com

Adlai Nortye: A Deep Dive (NASDAQ:ANL)

ADSs of cancer therapy concern Adlai Nortye Group (ANL) have rallied 1,606% since early December 2025, largely on confidence inspired by two private...
seekingalpha.com

Interest Rates Will Increasingly Crimp The U.S. Economy

Rising interest rates hit housing, big-ticket goods & commercial real estate. Click to read this detailed investing strategy.
seekingalpha.com

BioNTech SE: A Deep Dive (NASDAQ:BNTX)

Shares of Covid-19 vaccine and oncology concern BioNTech SE (BNTX) have remained primarily in a range of $80 to $120 over the past 40 months as the market...
seekingalpha.com

The Option Play Of The Week (NYSE:YOU)

Shares of airport security line-cutting service Clear Secure, Inc.